The impact of severe mental illness (SMI) on the rate of COVID-19 vaccine uptake and hesitancy
Introduction The COVID-19 pandemic has disproportionately affected patients with severe mental illness (SMI), a vulnerable population with high morbidity and mortality. A UK-based study found reduced vaccination rates in patients with SMI; they therefore need to be prioritised for prevention and di...
Main Authors: | T. Hamakarim, A. Arumuham, S. Parmar, O. D. Howes |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2023-03-01
|
Series: | European Psychiatry |
Online Access: | https://www.cambridge.org/core/product/identifier/S092493382300977X/type/journal_article |
Similar Items
-
Reducing COVID-19 vaccine hesitancy and improving vaccine uptake in Nigeria
by: Amenze Eguavoen, et al.
Published: (2023-05-01) -
COVID-19 vaccine hesitancy: Considerations for reluctance and improving vaccine uptake
by: Kaushal Parimi, et al.
Published: (2022-11-01) -
Prevalence of vaccination against the Covid19 within mentally ill population and acceptance and hesitancy factors
by: K. Makni, et al.
Published: (2022-06-01) -
COVID-19 vaccine hesitancy in patients with mental illness: strategies to overcome barriers—a review
by: Ebrahim Payberah, et al.
Published: (2022-01-01) -
The impact of national income and vaccine hesitancy on country-level COVID-19 vaccine uptake.
by: Javad Moradpour, et al.
Published: (2023-01-01)